{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:09:29Z","timestamp":1782925769271,"version":"3.54.5"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jinf.2019.10.019","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T03:18:05Z","timestamp":1573701485000},"page":"232-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience"],"prefix":"10.1016","volume":"80","author":[{"given":"L","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Eveson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Foxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.10.019_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jinf.2017.05.008","article-title":"Direct-acting antiviral treatment against hepatitis C virus infection in HIV-infected patients \u2013 \u201cEn route for eradication\u201d","volume":"75","author":"Pradat","year":"2017","journal-title":"Journal of Infection"},{"key":"10.1016\/j.jinf.2019.10.019_bib0002","year":"2012","journal-title":"HIV and Hepatitis C Co-infection"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.019_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jinf.2019.05.005","article-title":"Higher relapse rate among HIV\/HCV-coinfected patients receiving sofosbuvir\/ledipasvir for 8 vs 12 weeks","volume":"79","author":"Corma-G\u00f3mez","year":"2019","journal-title":"Journal of Infection"},{"issue":"6","key":"10.1016\/j.jinf.2019.10.019_bib0004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jinf.2015.09.013","article-title":"Telaprevir-based therapy for treatment of HIV-1 and hepatitis c virus co-infected patients: an early access programme","volume":"71","author":"Gori","year":"2015","journal-title":"Journal of Infection"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:34Z","timestamp":1759008514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319303330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0163445319303330"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.019","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}